Integriderm, of Huntsville, Alabama, together with its partner Invitrogen, has launched PharmArray, a new microarray with genes specifically selected for toxicology and pharmacology research on ADME (absorption, distribution, metabolism, and excretion). The nylon-based array, which is designed to be reused up to five times, contains 4,400 human cDNAs that relate to hepatic, renal, neural, and gastrointestinal function.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.